Arsanis, Inc. Business Finance Contracts & Agreements

81 Contracts & Agreements
Browse by Subcategory
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
First Amendment to Second Amended and Restated Loan and Security Agreement among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules Capital, Inc., and Lenders
Loan Agreements
Arsanis, Inc.
Biotechnology
CA
2023
X4 Pharmaceuticals, Inc. Amended and Restated 2017 Employee Stock Purchase Plan
Equity Distribution Agreements
Arsanis, Inc.
Biotechnology
DE
2023
Registration Rights Agreement between X4 Pharmaceuticals, Inc. and Investors (May 15, 2023)
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2023
Securities Purchase Agreement between X4 Pharmaceuticals, Inc. and Investors (May 15, 2023)
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2023
X4 Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock (May 2023)
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2023
X4 Pharmaceuticals, Inc. Class C Warrant to Purchase Common Stock (December 2022)
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2022
X4 Pharmaceuticals, Inc. Pre-Funded Warrant to Purchase Common Stock (December 2022)
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2022
Underwriting Agreement between X4 Pharmaceuticals, Inc. and Piper Sandler & Co., Stifel, Nicolaus & Company, and Cantor Fitzgerald & Co. (December 7, 2022)
Underwriting Agreements
Arsanis, Inc.
Biotechnology
NY
2022
Amendment No. 4 to Loan and Security Agreement among X4 Pharmaceuticals, Inc., Subsidiaries, and Hercules Capital, Inc.
Loan Agreements
Arsanis, Inc.
Biotechnology
2022
Registration Rights Agreement between X4 Pharmaceuticals, Inc. and Investors (June 30, 2022)
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement between X4 Pharmaceuticals, Inc. and Investors (June 30, 2022)
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2022
X4 Pharmaceuticals, Inc. Form of Warrant to Purchase Common Stock or Pre-Funded Warrants (July 2022)
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2022
X4 Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Registration Rights Agreement between X4 Pharmaceuticals, Inc. and Investors (March 3, 2022)
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Securities Purchase Agreement between X4 Pharmaceuticals, Inc. and Investors (March 3, 2022)
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2022
X4 Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock (March 2022)
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2022
Amendment No. 3 to Loan and Security Agreement among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules Capital, Inc., and Lenders
Loan Agreements
Arsanis, Inc.
Biotechnology
2022
Registration Rights Agreement between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (January 14, 2022)
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
IL
2022
Purchase Agreement between X4 Pharmaceuticals, Inc. and Lincoln Park Capital Fund, LLC (January 14, 2022)
Purchase Agreements
Arsanis, Inc.
Biotechnology
IL
2022
Registration Rights Agreement between X4 Pharmaceuticals, Inc. and Investors (November 5, 2021)
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Securities Purchase Agreement between X4 Pharmaceuticals, Inc. and Investors (November 5, 2021)
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2021
X4 Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Third Amendment to Option Agreement between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Modification Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Second Amendment to Option Agreement between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Modification Agreements
Arsanis, Inc.
Biotechnology
DE
2021
First Amendment to Option Agreement between X4 Pharmaceuticals, Inc. and Abingworth Bioventures 8 LP
Modification Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Registration Rights Agreement between X4 Pharmaceuticals, Inc. and Investors (March 18, 2021)
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Securities Purchase Agreement between X4 Pharmaceuticals, Inc. and Investors (March 18, 2021)
Purchase Agreements
Arsanis, Inc.
Biotechnology
DE
2021
X4 Pharmaceuticals, Inc. Form of Pre-Funded Warrant to Purchase Common Stock
Warrant Agreements
Arsanis, Inc.
Biotechnology
DE
2021
Second Amendment to Loan and Security Agreement among X4 Pharmaceuticals, Inc., Subsidiaries, and Hercules Capital, Inc.
Loan Agreements
Arsanis, Inc.
Biotechnology
2020
Common Stock Purchase Agreement between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (October 14, 2020)
Purchase Agreements
Arsanis, Inc.
Biotechnology
IL
2020
Registration Rights Agreement between X4 Pharmaceuticals, Inc. and Aspire Capital Fund, LLC (October 14, 2020)
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
IL
2020
Amendment No. 1 to Loan and Security Agreement among X4 Pharmaceuticals, Inc., its Subsidiaries, and Hercules Capital, Inc.
Loan Agreements
Arsanis, Inc.
Biotechnology
2020
Amendment No. 1 to Master Services Agreement between Mayne Pharma Inc. and X4 Pharmaceuticals Inc.
Modification Agreements
Arsanis, Inc.
Biotechnology
2020
Description of Common Stock and Registration Rights under Share Purchase Agreement with NEA
Registration Rights Agreements
Arsanis, Inc.
Biotechnology
2020
X4 Pharmaceuticals, Inc. Class B Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2019
X4 Pharmaceuticals, Inc. Pre-Funded Warrant to Purchase Common Stock (Form of Warrant)
Warrant Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Underwriting Agreement among X4 Pharmaceuticals, Inc. and Cowen and Company, LLC and Stifel, Nicolaus & Company, Incorporated
Underwriting Agreements
Arsanis, Inc.
Biotechnology
NY
2019
Amended and Restated Loan and Security Agreement, dated as of June 27, 2019, by and among X4 Pharmaceuticals, Inc., X4 Therapeutics, Inc., Hercules Capital, Inc. and Hercules...
Loan Agreements
Arsanis, Inc.
Biotechnology
CA
2019
Warrant Agreement, dated as of March 18, 2019, by and between the Company and Hercules Capital, Inc
Warrant Agreements
Arsanis, Inc.
Biotechnology
CA
2019
Amended and Restated Warrant Agreement, dated as of March 29, 2019, by and between the Company and Hercules Capital, Inc
Warrant Agreements
Arsanis, Inc.
Biotechnology
CA
2019